Androgen receptor modulation optimized for response—splice variant: a phase 3, randomized trial of galeterone versus enzalutamide in androgen receptor splice …

ME Taplin, ES Antonarakis, KJ Ferrante, K Horgan… - European urology, 2019 - Elsevier
Background: Detection of androgen receptor (AR) splice variant-7 (AR-V7) messenger RNA
(mRNA) in circulating tumor cells (CTCs) is associated with a suboptimal response to …
被引用次数：44 相关文章

Androgen Receptor Modulation Optimized for Response-Splice Variant: A Phase 3, Randomized Trial of Galeterone Versus Enzalutamide in Androgen Receptor …

ME Taplin, ES Antonarakis, KJ Ferrante, K Horgan… - European …, 2019 - hero.epa.gov
BACKGROUND: Detection of androgen receptor (AR) splice variant-7 (AR-V7) messenger
RNA (mRNA) in circulating tumor cells (CTCs) is associated with a suboptimal response to …

Androgen Receptor Modulation Optimized for Response—Splice Variant: A Phase 3, Randomized Trial of Galeterone Versus Enzalutamide in Androgen Receptor …

ME Taplin, ES Antonarakis, KJ Ferrante… - European …, 2019 - pure.johnshopkins.edu
Background:: Detection of androgen receptor (AR) splice variant-7 (AR-V7) messenger RNA
(mRNA) in circulating tumor cells (CTCs) is associated with a suboptimal response to …

Androgen Receptor Modulation Optimized for Response-Splice Variant: A Phase 3, Randomized Trial of Galeterone Versus Enzalutamide in Androgen Receptor …

ME Taplin, ES Antonarakis, KJ Ferrante… - European …, 2019 - pubmed.ncbi.nlm.nih.gov
Background Detection of androgen receptor (AR) splice variant-7 (AR-V7) messenger RNA
(mRNA) in circulating tumor cells (CTCs) is associated with a suboptimal response to …

Androgen Receptor Modulation Optimized for Response—Splice Variant: A Phase 3, Randomized Trial of Galeterone Versus Enzalutamide in Androgen Receptor …

ME Taplin, ES Antonarakis, KJ Ferrante… - European …, 2019 - experts.umn.edu
Background:: Detection of androgen receptor (AR) splice variant-7 (AR-V7) messenger RNA
(mRNA) in circulating tumor cells (CTCs) is associated with a suboptimal response to …

Androgen Receptor Modulation Optimized for Response-Splice Variant: A Phase 3, Randomized Trial of Galeterone Versus Enzalutamide in Androgen Receptor …

ME Taplin, ES Antonarakis, KJ Ferrante… - European …, 2019 - europepmc.org
Background Detection of androgen receptor (AR) splice variant-7 (AR-V7) messenger RNA
(mRNA) in circulating tumor cells (CTCs) is associated with a suboptimal response to …